ADMET and DMPK  

Nanotechnology platforms in Parkinson’s Disease

Rishi Rajat Adhikary, Puja Sandbhor, Rinti Banerjee

Abstract


Parkinson’s disease (PD) remains a serious concern due to its effects on the quality of life of patients and its socioeconomic burden to society. Present day management of PD has limitations in both diagnosis and treatment. Nanotechnology may provide smart solutions to this problem. The present review highlights the recent advancements in the development of nanotechnology platforms for PD. The review focuses on the use of such platforms in diagnostics, treatments, deep brain stimulation, neurosurgery and other modalities of management and the role of nanotechnology in each of these fields. The review also sheds light on the translation of technologies from labs to clinics and the essential advantages as well as concerns that accompany the translation.


Full Text:

PDF


DOI: http://dx.doi.org/10.5599/admet.3.3.189

Refbacks

  • There are currently no refbacks.


ISSN 1848-7718